Neurotoxicity screening evaluates the effects of compounds on the nervous system, helping researchers identify potential neurotoxicants and assess drug safety. This process involves in vitro and in vivo models, including induced pluripotent stem cell (iPSC)-derived neurons and multi-well microelectrode arrays (mwMEAs), to measure neurotoxic responses. Scientists use neurotoxicity screening to study disease mechanisms, optimize drug formulations, and improve therapeutic strategies for neurological disorders.
